Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1996 1
1997 1
1999 1
2002 1
2003 1
2004 5
2007 3
2008 3
2009 6
2010 3
2011 6
2012 4
2013 14
2014 8
2015 17
2016 7
2017 5
2018 3
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24665346

91 results
Results by year
Filters applied: . Clear all
Page 1
Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.
Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M. Ozaki K, et al. J Cancer. 2014 Mar 4;5(3):221-30. doi: 10.7150/jca.7691. eCollection 2014. J Cancer. 2014. PMID: 24665346 Free PMC article.
Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality.
Youssef AA, Issa HA, Omar MZ, Behiry EG, Elfallah AA, Hasaneen A, Darwish M, Ibrahim DB. Youssef AA, et al. Clin Exp Gastroenterol. 2018 Nov 23;11:431-438. doi: 10.2147/CEG.S171339. eCollection 2018. Clin Exp Gastroenterol. 2018. PMID: 30538523 Free PMC article.
Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.
Tamai T, Uto H, Takami Y, Oda K, Saishoji A, Hashiguchi M, Kumagai K, Kure T, Mawatari S, Moriuchi A, Oketani M, Ido A, Tsubouchi H. Tamai T, et al. World J Gastroenterol. 2011 Nov 28;17(44):4890-8. doi: 10.3748/wjg.v17.i44.4890. World J Gastroenterol. 2011. PMID: 22171130 Free PMC article.
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. Meguro M, et al. World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933. World J Gastroenterol. 2015. PMID: 25945007 Free PMC article.
Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Nault JC, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet JC, Coelho J, Lasalle P, Charnaux N, Delehedde M, Sutton A, Nahon P. Nault JC, et al. Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1343-52. doi: 10.1158/1055-9965.EPI-13-0179. Epub 2013 Jun 18. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23780836 Free article.
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S. Imamura H, et al. Br J Surg. 1999 Aug;86(8):1032-8. doi: 10.1046/j.1365-2168.1999.01185.x. Br J Surg. 1999. PMID: 10460639
Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I. Bertino G, et al. Minerva Med. 2011 Oct;102(5):363-71. Minerva Med. 2011. PMID: 22193346 Review.
Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
Chon YE, Choi GH, Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY. Chon YE, et al. Int J Cancer. 2012 Nov 15;131(10):2332-41. doi: 10.1002/ijc.27507. Epub 2012 Mar 28. Int J Cancer. 2012. PMID: 22362471 Free article.
Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S, Rhim H, Kim YS, Kang TW, Song KD. Lee S, et al. Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18. Liver Int. 2016. PMID: 26503910
High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL. Lv Y, et al. Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31. Eur J Surg Oncol. 2013. PMID: 23916473
91 results
Jump to page
Feedback